DUSA, Sun Pharmaceutical deal

Sun will acquire DUSA for $8 per share in cash, or

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE